Bernstein Upgrades Eni to Outperform
Bernstein analyst Oswald Clint upgrades Eni (NYSE:E) from Market Perform to Outperform.
Barclays Upgrades KeyCorp to Equal-Weight, Raises Price Target to $24
Barclays analyst Jason Goldberg upgrades KeyCorp (NYSE:KEY) from Underweight to Equal-Weight and raises the price target from $21 to $24.
Wells Fargo Upgrades Wynn Resorts to Overweight, Raises Price Target to $101
Wells Fargo analyst Daniel Politzer upgrades Wynn Resorts (NASDAQ:WYNN) from Equal-Weight to Overweight and raises the price target from $74 to $101.
Redburn Partners Upgrades CRH to Buy
Redburn Partners analyst Will Jones upgrades CRH (NYSE:CRH) from Neutral to Buy.
Wells Fargo Upgrades Monte Rosa Therapeutics to Overweight, Announces $19 Price Target
Wells Fargo analyst Derek Archila upgrades Monte Rosa Therapeutics (NASDAQ:GLUE) from Equal-Weight to Overweight and announces $19 price target.
Wells Fargo Upgrades Blueprint Medicines to Equal-Weight, Announces $41 Price Target
Wells Fargo analyst Derek Archila upgrades Blueprint Medicines (NASDAQ:BPMC) from Underweight to Equal-Weight and announces $41 price target.
Benzinga’s Top Ratings Upgrades, Downgrades For December 30, 2022
Upgrades See all analyst ratings upgrades. Downgrades For Micron Technology Inc (NASDAQ:MU), Argus Research downgraded the previous rating…
Why This Netflix Analyst Is Double Upgrading The Streaming Stock: ‘Difficult For Competitors To Catch’
New content and catalysts from Netflix Inc (NASDAQ: NFLX) have one analyst upgrading the streaming stock and lifting their price target ahead of the new year.
Benzinga’s Top Ratings Upgrades, Downgrades For December 29, 2022
Upgrades CFRA upgraded the previous rating for Netflix Inc (NASDAQ:NFLX) from Sell to Buy. Netflix earned $3.10 in…
CFRA Upgrades Netflix to Buy, Announces $310 Price Target
CFRA analyst Kenneth Leon upgrades Netflix (NASDAQ:NFLX) from Sell to Buy and announces $310 price target.